A putative gene fgaMT was identified in the biosynthetic gene cluster of fumigaclavines in Aspergillus fumigatus. The coding region of fgaMT was amplified by PCR from a cDNA library, cloned into pQE60 and overexpressed in E. coli. FgaMT comprises 339 amino acids with a molecular weight of about 38.1 kDa. The soluble dimeric His 6 -FgaMT was purified to near homogeneity and characterised biochemically. FgaMT was found to catalyse the N-methylation of 4-dimethylallyltryptophan in the presence of S-adenosylmethionine resulting in the formation of 4-dimethylallyl-L-abrine, which was identified by NMR and MS analysis. Therefore, FgaMT represents the second pathway-specific enzyme in the biosynthesis of ergot alkaloids. The enzyme did not require metal ions for its enzymatic reaction and showed a relatively high specificity towards the prenyl moiety at position C-4 of the indole ring. 4-dimethylallyltryptophan derivatives with modification at the indole ring were also accepted by FgaMT as substrates. K m values for 4-dimethylallyltryptophan and S-adenosylmethionine were determined at 0.12 and 2.4 mM, respectively. The turnover number was 2.0 s -1 .
INTRODUCTION
Ergot alkaloids are a complex family of indole derivatives with diverse biological activities (1) and produced mainly by fungi of the genera Claviceps, Penicillium and Aspergillus (1,2). Ergot alkaloids can be divided into two classes of compounds according to their structural features: the clavines and D-lysergic acid amides (2,3). The clavines merely consist of the tetracyclic ergoline ring, e.g. agroclavine, fumigaclavines A and C (Figure 1 ) or its tricyclic seco derivatives, e.g. chanoclavine-I ( Figure 1 ). D-lysergic acid-containing alkaloids, on the other hand, have substituents attached by amide bonds to the ergoline ring system. These substituents can be amino alcohols or tripeptide chains arranged in a unique bicyclic arrangement. The latter compounds are called ergopeptines, e.g. ergotamine (Figure 1) , and are widely used as therapeutic agents (1) . Ergot alkaloids of the clavine-type are also biologically active. For example, in vitro experiments have shown that fumigaclavine C has various pharmacological activities such as improvement of experimental colitis (4) and concanavalin A-induced liver injury in mice (5) as well as relaxation of isolated rat aortic rings (6) .
The clavine-type alkaloids fumigaclavines are produced by Penicillium and Aspergillus, e.g. A. fumigatus (2), but not by the fungal family of the Clavicipitaceae, e.g. C. purpurea (2). Conversely, the amides and peptides of lysergic acid are produced by C. purpurea, but not by A. fumigatus (2). In contrast, agroclavine was identified in both fungal groups (2). Therefore, we have proposed that the early stages of the biosynthetic pathway of ergot alkaloids up to agroclavine are shared by A. fumigatus and C. purpurea, whereas later steps in the pathways differ in the two fungi ( Figure 1 ) (7).
The biosynthesis of ergot alkaloids has been studied for more than 50 years, especially in the fungus Claviceps species and mainly by feeding experiments with isotope-labelled precursors and by enzyme extracts from the producers (1, 3, 8, 9) . The results of these studies revealed clearly that the ergoline moiety is derived from tryptophan and dimethylallyl diphosphate (DMAPP) (8, 9) . The biosynthesis of ergot alkaloids starts with the formation of 4-dimethylallyltryptophan (4-DMAT) catalysed by the first pathway-specific enzyme, 4-dimethylallyltryptophan synthase (DmaW). The tetracylic ergolene, agroclavine, was formed by methylation of 4-DMAT to 4-DMA-L-abrine and two subsequent oxidative ring closures along with decarboxylation of 4-DMA-L-abrine ( Figure 1 ).
Investigation of the ergot alkaloid biosynthesis on molecular biological level began with the identification of the dmaW gene, which was amplified with PCR by using degenerate primers obtained from the purified 4-dimethylallyltryptophan synthase of Claviceps fusiformis (reported as Claviceps purpurea) (10) . By using the dmaW sequence, Tudzynski et al. identified a biosynthetic gene cluster of ergot alkaloids in C. purpurea (11) . The functions of three genes from this cluster, cloA, cpps1 and cpps2 coding CloA, LPS1 and LPS2, respectively, were proven experimentally. The cytochrome P450 enzyme CloA catalyses the conversion of elymoclavine to paspalic acid (12) . LPS1 and LPS2 are involved in the connection of the tripeptidyl with lysergyl moieties (13, 14) . Therefore, all three enzymes catalyse the reactions in the biosynthesis of ergopeptines after formation of agroclavine (Figure 1 ).
By bioinformatic approaches, a biosynthetic gene cluster of fumigaclavine C was identified in the genome of Aspergillus fumigatus Af293 (7, 15, 16) . Functional proof of this cluster was provided by gene inactivation experiment (16) and by heterologous expression and biochemical characterisation of two prenyltransferase genes fgaPT1 and fgaPT2 (15, 17) . FgaPT2 and FgaPT1 catalyse the first and last pathway-specific reaction steps in the biosynthesis of fumigaclavine C, respectively. The identification of this cluster provides a convenient way to identify candidate genes for the early stages of the biosynthesis of ergot alkaloids by comparison of the two clusters in C. purpurea and A. fumigatus. Seven homologous genes are found in the biosynthetic gene cluster of fumigaclavines in A. fumigatus Af293 and of ergot alkaloids in C. purpurea (15, 16) . These seven genes are proposed to be responsible for the common steps in the biosynthesis of fumigaclavines from A. fumigatus and of ergot alkaloids from C. purpurea, i.e. agroclavine (17) (Figure 1 ).
The identification of the biosynthetic gene cluster of fumigaclavine C provides also additional opportunities to investigate the function of genes involved in the formation of the clavine skeleton with genes from both clusters. Functional proof of genes and enzymes involved in the biosynthesis of secondary metabolites is the prerequisite for production of biologically active substances by using biochemical and molecular biological approaches such as combinatorial biosynthesis, mutasynthesis or chemoenzymatic synthesis. Combinatorial biosynthesis was defined as the application of genetic engineering to modify biosynthetic pathways of natural products in order to produce new and altered structures using nature´s biosynthetic machinery (18) . Mutasynthesis or mutational biosynthesis combines genetic and chemical approaches and was successfully used in a number of bacterial systems to produce biologically active substances (19) (20) (21) . Chemoenzymatic synthesis is an in vitro approach with help of purified proteins and was used successfully in the synthesis of peptides (22) , glycopeptides (23) , nucleotide deoxysugars (24) , glycan libraries (25) and glycosides (26) .
As mentioned above, only one enzyme in the biosynthesis of agroclavine was functionally identified until now, i.e. the first pathway-specific enzyme of the ergot alkaloid biosynthesis DmaW from C. fusiformis (10) and its orthologue in Neotyphodium lolii x Epichloë typhina (27) as well as FgaPT2 from A. fumigatus (15) . Here we report on the biochemical characterisation of an N-methyltransferase catalysing the second step of the ergot alkaloid biosynthesis in A. fumigatus as well as its specificity towards aromatic substrates. was used for selection of recombinant E. coli strains.
EXPERIMENTAL PROCEDURES

Computer
DNA isolation, PCR amplification and cloning.
Standard procedures for DNA isolation and manipulation were performed as described (29) . PCR amplification was carried out on an iCycler from BioRad (Munich, Germany).
A PCR fragment of 1034 bp containing the entire coding sequence of fgaMT was amplified using Expand High Fidelity Kit (Roche Diagnostics GmbH, Mannheim, Germany) from the cDNA library of A. fumigatus B5233 rather than the genome reference strain Af293 by using the primers fgaMT-for (5´-CAGCCACCATGGCGATTTCAGCTCC-3´) at the 5´-end and fgaMT_rev2 (5´-CATGGATCCGTTCAGACGCAGTCTCA A-3´) at the 3´-end of the gene. Bold letters represent mutations inserted in comparison to the original genome sequence to give the underlined restriction sites NcoI located at the start codon in fgaMT_for and BamHI located at the predicted stop codon in fgaMT_rev2. The PCR fragment was cloned into pGEM-T resulting in plasmid pOR13 which was subsequently sequenced (MWG Biotech AG, Ebersberg, Germany) to confirm the sequence. To create the expression vector pOR15, pOR13 was digested with NcoI and BamHI and the resulted NcoI -BamHI fragment of 1023 bp was ligated into pQE60, which had been digested with the same enzymes, previously.
Overproduction and purification of His 6 -FgaMT. For gene expression, E. coli XL1 Blue MRF´ cells harbouring the plasmid pOR15 were cultivated in 300 ml Erlenmeyer flasks containing 100 ml liquid Luria-Bertani medium supplemented with carbenicillin (50 µg ml -1 ) and grown at 37 °C to an OD 600 of 0.6. For induction, isopropyl thiogalactoside (IPTG) was added to a final concentration of 1 mM and the cells were cultivated for further 16 h at 37 °C before harvest. The bacterial cultures were centrifuged and the pellets were resuspended in lysis buffer (10 mM imidazole, 50 mM NaH 2 PO 4 , 300 mM NaCl, pH 8.0) at 2-5 ml per gram wet weight. After addition of 1 mg ml -1 lysozyme and incubation on ice for 30 min, the cells were sonicated 6 times for 10 seconds each at 200 W.
To separate the cellular debris from the soluble proteins, the lysate was centrifuged at 14,000 x g for 30 min at 4°C. One-step purification of the recombinant His 6 -tagged fusion protein by affinity chromatography with Ni-NTA agarose resin (Qiagen, Hilden, Germany) was carried out according to the manufacturer's instructions. The protein was eluted with 250 mM imidazole in 50 mM NaH 2 PO 4 , 300 mM NaCl, pH 8.0. In order to change the buffer, the protein fraction was passed through a NAP-5 column (GE Healthcare, Freiburg, Germany), which had been equilibrated with 50 mM Tris-HCl, 15 % (v/v) of glycerol, pH 7.5, previously. FgaMT was eluted with the same buffer and stored frozen at -80 °C for enzyme assays.
Protein analysis. Proteins were analysed by SDS-PAGE according to the method of Laemmli (30) , and stained with Coomassie Brilliant Blue G-250. Tandem assays with FgaPT2 and FgaMT. All of the enzyme assays contained 50 mM Tris-HCl, pH 7.5, 1.2 -3.8 % (v/v) of glycerol. They differed from each other by incubation volume and time, substrate concentration and amount of the recombinant FgaMT. The reaction mixtures were incubated at 37 °C and the reactions were terminated by addition of 100 µl methanol per 100 µl reaction mixtures. After removal of the protein by centrifugation (14,000 x g, 10 min, 4 °C), the enzymatic products were analysed on a HPLC system described below. The enzyme assays of FgaPT2 (100 µl) contained 1 mM L-tryptophan or its derivatives, 2 mM DMAPP, 5 mM CaCl 2 and 20 µg (180 pmol) of FgaPT2. After conversion of L-tryptophan or its derivatives to 4-DMAT and its respective derivatives by incubation at 37 °C for 16 hr, aliquots of the reaction mixture in 50 µl were used for FgaMT assays, which contained 1 mM SAM, different amounts of purified FgaMT and had a final volume of 100 µl. Two independent assays were carried out routinely. The assays for determination of the kinetic parameters (100 µl) of 4-DMAT contained 5.0 mM SAM, 1 µg ( -methyl-DL-tryptophan with FgaMT were detected by method 2 and 3 described below, respectively. All other assays were analysed by using a gradient from 30 % to 70 % B in 23 min. After washing with 100 % solvent B for 5 min, the column was equilibrated with 70 % solvent A for 7 min. 4-dimethylallyl-L-abrine was isolated under the same condition.
Determination of molecular weight of active
HPLC analysis of L-tryptophan and L-abrine (method 2).
For identification of incubation mixture of FgaMT with L-tryptophan, the same HPLC equipment as for the analysis of 4-dimethylallyl-L-abrine was used, but with following gradient: From 15 % A to 70 % B in 15 min. After washing with 100 % solvent B for 5 min, the column was equilibrated with 85 % solvent A for 5 min. (31) .
HPLC analysis of 4-methyl-DL-tryptophan and 4-methylabrine (method 3).
ESI-MS of the enzymatic products.
The positive and negative electrospray ionisation (ESI) mass spectrometry was carried out with a ThermoFinnigan TSQ Quantum. The mass spectrometer was coupled with an Agilent HPLC series 1100 equipped with a RP18-column (2 x 250 mm, 5 µm). For separation, the column was run with 10 % solvent B (methanol) in solvent A (water, each containing 0.1 % HCOOH) for 5 min, followed by a gradient from 10 % to 100 % B over 30 min. After washing with 100 % B, the column was equilibrated with 10 % B for 10 min. The flow rate was at 0.2 ml min -1 .The results of mass spectroscopic analysis are given in Table 1 .
Nucleotide sequence accession number. The nucleotide sequence of the genomic DNA from A. fumigatus Af293 reported in this study is available at GenBank under the accession number AAHF01000001.1. The coding sequence of fgaMT from A. fumigatus B5233 was deposited at GenBank under the accession number EU827256. Cloning of fgaMT, overproduction and purification of His 6 -FgaMT. To prove the function of AFUA_2G18060, we have amplified its orthologue in A. fumigatus strain B5233, termed fgaMT in this study, by using PCR from a cDNA library in phagemid form. The PCR product of 1034 bp was cloned into the cloning vector pGEM-T resulting in pOR13. Sequencing of pOR13 confirmed the predicted gene sequence and exon/intron structure. For gene expression, the coding sequence of fgaMT was released from pOR13 and cloned into the expression vector pQE60 for E. coli to give the expression construct pOR15. Figure 3A) , as observed in our previous studies (15, 31 ). This reaction mixture was then incubated with the purified FgaMT and S-adenosylmethionine (SAM). As shown in Figure 3B , an additional peak at 12.3 min could be detected in the HPLC chromatogram. This peak had a same retention time as 4-dimethylallyl-L-abrine ( Figure 3C ), which was obtained by an incubation of L-abrine with FgaPT2 in the presence of DMAPP (31). Formation of the peak at 12.3 min was dependent on the presence of SAM and active recombinant FgaMT (Figures 3D and 3E) . Product formation showed a linear dependence on the amount of protein up to 5 μg per 100 μl assay and on the incubation time up to 60 min (data not shown).
RESULTS
Sequence
For structural elucidation, the enzymatic product was subsequently isolated on a preparative scale (see EXPERIMENTAL PROCEDURES) and subjected to NMR and MS analysis. (Table 1) . But its stereochemistry was not determined in this study, which is also true for other FgaMT products described below. To investigate substrate specificity of FgaMT towards further aromatic substances, D-tryptophan and different tryptophan derivatives carrying methyl groups at the indole ring were tandem incubated with FgaPT2 in the presence of DMAPP and FgaMT in the presence of SAM ( Figure 6 ). As reported previously (31) , all of these compounds were accepted by FgaPT2 and converted to the respective 4-DMAT derivatives as determined by LC-MS analysis ( Table 1 ). The conversion rates of 5-, 6-and 7-methyl-DL-tryptophan by FgaPT2 increased with the increasing distance of the methyl group to the prenylation position at C-4, corresponding well to the reported results (31) . In comparison to FgaPT2, which accepted also D-tryptophan as substrate (Figure 6 ), FgaMT showed a much higher stereoselectivity.
As shown in Figure 6 , the FgaPT2 product of D-tryptophan was not accepted by FgaMT. In contrast, 5-, 6-and 7-methyl-DMAT were converted by FgaMT to methylated derivatives ( Figure 6 ). This was confirmed by detection of Figure 6 , however, it is obvious that 7-methyl-4-DMAT was better accepted by FgaMT than 5-and 6-methyl-4-DMAT. Therefore, methyltransferases involved in these processes are interesting candidates as pharmacological and therapeutic targets (39) . SAM-dependent methyltransferases are also involved in the biosynthesis of many secondary metabolites (42) . For example, N-methyltransferases catalyse important steps in the biosynthesis of alkaloids such as tropane (43), protopine (44), acridone (45) and purine alkaloids (46,47). N-methyltransferase domains in NRPS and hybrid NRPS/PKS are responsible for the N-methylation of amino acids in many natural products (48).
In this study, we have cloned and overexpressed the putative methyltransferase gene fgaMT from the biosynthetic gene cluster of fumigaclavine C in the fungus A. fumigatus and characterised the overproduced protein biochemically. The enzymatic product was identified unequivocally as 4-dimethylallyl-L-abrine by NMR and MS analysis. Therefore, FgaMT catalyses the methylation at NH 2 group of 4-DMAT in the presence of SAM. It is expected that the homologues of FgaMT, OrfB (=EasF), in different fungi such as Claviceps purpurea (1), Claviceps fusiformis (32) and Neotyphodium lolii (32) catalyse the same reaction as FgaMT. Therefore, the results presented in this study also enhance our understanding on the biosynthesis of the pharmaceutically important ergot alkaloids in C. purpurea. To the best of our knowledge, FgaMT belongs to a new enzyme group of SAM-dependent methyltransferases. With the exception to its orthologues in fungi mentioned above, FgaMT shows no significant sequence similarity to known entries in database. No conserved motifs for methyltransferases (34, 35) could be found in the sequence of FgaMT.
In the biosynthesis of ergot alkaloids, L-tryptophan is converted to 4-dimethylallyl-L-abrine by prenylation at position C-4 and methylation at the NH 2 group. It was reported that the prenylation takes place before methylation (36). However, our previous results showed that L-abrine was well accepted by the prenyltransferase FgaPT2 as substrate (31) , which was well reproduced in this study (Figure 3) . It seems that the prenylation could take place after the methylation. But, L-tryptophan had a much higher affinity with a K m value of 9 µM to FgaPT2 than L-abrine with a K m value of 130 µM. This strongly suggested that the prenyltransferase is the first pathway-specific enzyme (15, 31) from Papaver somniferum were determined for stylopine and SAM at 0.6 and 11.5 µM, respectively (44). However, the K m values of FgaMT from A. fumigatus reported here corresponded well to the data obtained for the 4-DMAT methyltransferase activity of a crude enzyme extract from Claviceps sp. strain SD58 in the range from 0.11 to 0.27 mM for 4-DMAT and from 0.5 to 1.6 mM for SAM, respectively (36).
In our previous study (31) , we have demonstrated that different methylated tryptophan derivatives were also accepted by FgaPT2, the first pathway-specific enzyme in the biosynthesis of ergot alkaloids, as substrates and converted to the corresponding 4-DMAT derivatives. In this study, we have shown that some of these derivatives, e.g. 5-, 6-, and 7-methyl-4-DMAT were also accepted by FgaMT, the second pathway-specific enzyme in the biosynthesis (Figures 1 and 6 ). Even 4-methyl-DL-tryptophan was accepted by FgaMT and a relative conversion rate of about 9 % of 4-DMAT was determined, corresponding well to 10 % obtained with a 4-DMAT methyltransferase from a crude enzyme extract of Claviceps sp. strain SD58 (36). 4-D-DMAT, which was obtained by incubation of D-tryptophan with FgaPT2 in the presence of DMAPP, was not accepted by FgaMT, indicating a high stereoselectivity. However, 7-methyl-4-DMAT in a concentration of 0.37 mM, which is estimated by a conversion rate of 74 % of 1 mM tryptophan and a dilution of 1:2 used for the FgaMT reaction, was converted to 7-methyl-4-DMA-abrine with a yield of 81.2 % ( Figure 6 ). This value is much higher than the expected conversion rate of 67.6 %, if it is assumed that only 7-methyl-4-L-DMAT but not 7-methyl-4-D-DMAT (at least 24 % of the product of the FgaPT2 reaction) was converted by FgaMT. The observed higher conversion rate of 7-methyl-4-DMAT indicates that FgaMT has a lower stereoselectivity towards 7-methyl-4-DMAT than 4-DMAT. In other words, methylation at the indole ring could decrease the preference of the enzyme for Lover D-configured substrates. Similar phenomenon was also observed with FgaPT2 (31). Methylation of 4-DMAT derivatives by the second pathway-specific enzyme FgaMT to respective 4-dimethylallyl-L-abrine derivatives ( Figure 6 ) indicates that the biosynthetic enzymes of ergot alkaloids share broad substrate specificities. This feature of substrate flexibility makes these enzymes especially interesting for production of modified ergot alkaloids by molecular biological and biochemical methods (52). by guest on June 23, 2017 
